切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 456 -461. doi: 10.3877/cma.j.issn.1674-0793.2023.06.013

综述

胃癌预后预测模型的研究进展
张俊, 罗再, 段茗玉, 裘正军, 黄陈()   
  1. 200080 上海交通大学附属第一人民医院胃肠外科
  • 收稿日期:2023-02-20 出版日期:2023-12-01
  • 通信作者: 黄陈
  • 基金资助:
    国家自然科学基金面上项目(82072662); 上海市级医院临床技能与临床创新三年行动计划(SHDC2020CR4022); 上海交通大学医学院高峰高原计划(第二轮)(20191425); 上海市"医苑新星"杰出青年医学人才培养资助计划; 上海市第一人民医院特色国家领军人才培养计划

Research progress of prognostic prediction models for gastric cancer

Jun Zhang, Zai Luo, Mingyu Duan, Zhengjun Qiu, Chen Huang()   

  1. Department of Gastrointestinal Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200080, China
  • Received:2023-02-20 Published:2023-12-01
  • Corresponding author: Chen Huang
引用本文:

张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.

Jun Zhang, Zai Luo, Mingyu Duan, Zhengjun Qiu, Chen Huang. Research progress of prognostic prediction models for gastric cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 456-461.

胃癌由于早期症状不典型且缺乏特异性,检出率相对较低,导致许多患者在初次就诊时就已处于进展期。而进展期胃癌患者的生存预后总体较差且差异较大,5年生存率为20%~60%。因此,需要制定更加个性化的治疗策略来提高生存率,缩小不同患者的预后差异。建立准确、可靠又方便的胃癌预后评估模型是当前胃癌诊治中亟待解决的重要问题之一。Cox回归分析模型能够分析多种因素对患者预后的影响;列线图模型能够通过计算不同预后因素的得分,直观地显示不同预后因素对患者预后的贡献程度;神经网络模型可以自动学习,深度学习模型可以自动提取特征,建立高效的预测模型,适用于大规模数据的胃癌预后预测。诸如以上预测模型可以区分胃癌患者预后的危险程度,有望为个性化治疗方案和后续诊治提供参考,在一定程度上改善患者的预后生存。

Due to the atypical symptoms and lack of specificity, the detection rate of early gastric cancer is relatively low, leading to many patients already in advanced stage since first diagnosis. However, the prognosis of patients with advanced gastric cancer is generally poor and varies greatly, with the 5-year survival rate hovering between 20% and 60%. Therefore, it is necessary to develop more personalized treatment strategies to improve the survival rate of patients and reduce the difference in prognosis of different patients. The establishment of reliable models for gastric cancer is one of the important problems to be solved urgently in the diagnosis and treatment of gastric cancer. Cox regression analysis model can analyze the impact of multiple factors on the prognosis of patients; nomogram model can directly display the contribution of different prognostic factors to the prognosis of patients by calculating the scores of different prognostic factors; the artificial neural network model can be automatically learned, and the deep learning model can automatically extract features to establish an efficient prediction model, which are applicable to the prognosis prediction of gastric cancer with large-scale data. The above predictive models may be used to differentiate the risk of gastric cancer, which is expected to provide personalized reference for follow-up treatment for patients, and improve the survival of patients to some extent.

表1 其他不同种类模型的预测能力
[1]
哈丽达·夏尔甫哈孜, 冯娟, 范晓棠, 等. 进展期胃癌根治术后5年预后因素分析及生存预测模型的建立[J]. 胃肠病学和肝病学杂志, 2020, 29(10): 1129-1133.
[2]
Strong VE, Wu AW, Selby LV, et al. Differences in gastric cancer survival between the U.S. and China[J]. J Surg Oncol, 2015, 112(1): 31-37.
[3]
Duan S, Wang P, Liu F, et al. Novel immune-risk score of gastric cancer: A molecular prediction model combining the value of immune-risk status and chemosensitivity[J]. Cancer Med, 2019, 8(5): 2675-2685.
[4]
Jiang Y, Zhang Q, Hu Y, et al. ImmunoScore signature: A prognostic and predictive tool in gastric cancer[J]. Ann Surg, 2018, 267(3): 504-513.
[5]
Wu C, Wang N, Zhou H, et al. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study[J]. Saudi J Gastroenterol, 2019, 25(4): 236-244.
[6]
Wang J, Qin D, Tao Z, et al. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer[J]. Front Immunol, 2022, 13: 1056932.
[7]
Shao W, Yang Z, Fu Y, et al. The pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer[J]. Front Cell Dev Biol, 2021, 9: 676485.
[8]
周新童, 党胜春. 基于不同数据库来源数据的胃癌长链非编码RNA预后预测模型构建[J]. 中国普通外科杂志, 2020, 29(10): 1187-1194.
[9]
Cai C, Yang L, Zhuang X, et al. A five-lncRNA model predicting overall survival in gastric cancer compared with normal tissues[J]. Aging, 2021, 13(21): 24349-24359.
[10]
Chen T, Zhang C, Liu Y, et al. A gastric cancer lncRNAs model for MSI and survival prediction based on support vector machine[J]. BMC Genomics, 2019, 20(1): 846.
[11]
Zhu Y, Fang X, Wang L, et al. A predictive nomogram for early death of metastatic gastric cancer: A retrospective study in the SEER database and China[J]. J Cancer, 2020, 11(18): 5527-5535.
[12]
Bando E, Ji X, Kattan MW, et al. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer[J]. Cancer Med, 2020, 9(16): 5708-5718.
[13]
Hu X, Yang Z, Chen S, et al. Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy[J]. Ann Transl Med, 2021, 9(23): 1742.
[14]
张原, 戎泽印, 黄陈. "偏近、朝远":基于原发部位胃癌发生机制研究进展及临床治疗决策思辨[J]. 中华普通外科杂志, 2021, 36(3): 230-234.
[15]
Jeong SH, Kim RB, Park SY, et al. Nomogram for predicting gastric cancer recurrence using biomarker gene expression[J]. Eur J Surg Oncol, 2020, 46(1): 195-201.
[16]
Bai Y, Wei C, Zhong Y, et al. Development and validation of a prognostic nomogram for gastric cancer based on DNA methylation-driven differentially expressed genes[J]. Int J Biol Sci, 2020, 16(7): 1153-1165.
[17]
Deng J, Liang H, Ying G, et al. Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer[J]. Am J Cancer Res, 2014, 4(6): 916-923.
[18]
Cao W, Zhou W, Li M, et al. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients[J]. Front Immunol, 2022, 13: 951135.
[19]
Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach[J]. Nat Commun, 2014, 5: 4006.
[20]
Wang Y, Liu W, Yu Y, et al. CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer[J]. Eur Radiol, 2020, 30(2): 976-986.
[21]
Jiang Y, Chen C, Xie J, et al. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer[J]. EBioMedicine, 2018, 36: 171-182.
[22]
Yoshida H, Shimazu T, Kiyuna T, et al. Automated histological classification of whole-slide images of gastric biopsy specimens[J]. Gastric Cancer, 2018, 21(2): 249-257.
[23]
Que SJ, Chen QY, Zhong Q, et al. Application of preoperative artificial neural network based on blood biomarkers and clinicopathological parameters for predicting long-term survival of patients with gastric cancer[J]. World J Gastroenterol, 2019, 25(43): 6451-6464.
[24]
Nilsaz-Dezfouli H, Abu-Bakar MR, Arasan J, et al. Improving gastric cancer outcome prediction using single time-point artificial neural network models[J]. Cancer Inform, 2017, 16: 1176935116686062.
[25]
Dong D, Fang MJ, Tang L, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: An international multicenter study[J]. Ann Oncol, 2020, 31(7): 912-920.
[26]
Jin C, Jiang Y, Yu H, et al. Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer[J]. Br J Surg, 2021, 108(5): 542-549.
[27]
Jiang Y, Zhang Z, Yuan Q, et al. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: A retrospective study[J]. Lancet Digit Health, 2022, 4(5): e340-e350.
[28]
Dai S, Liu T, Liu X Q, et al. Identification of an immune-related signature predicting survival risk and immune microenvironment in gastric cancer[J]. Front Cell Dev Biol, 2021, 9: 687473.
[29]
Cui Y, Zhang J, Li Z, et al. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study[J]. EClinicalMedicine, 2022, 46: 101348.
[30]
Dai S, Huang Y, Liu T, et al. Development and validation of RNA binding protein-applied prediction model for gastric cancer[J]. Aging (Albany NY), 2021, 13(4): 5539-5552.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[3] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[8] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[9] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[10] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[11] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[12] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[13] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[14] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
[15] 王亚丹, 吴静, 黄博洋, 王苗苗, 郭春梅, 宿慧, 王沧海, 王静, 丁鹏鹏, 刘红. 白光内镜下结直肠肿瘤性质预测模型的构建与验证[J]. 中华临床医师杂志(电子版), 2023, 17(06): 655-661.
阅读次数
全文


摘要